510(k) · Cleared
ClearedFemVue MINI Saline-Air Device
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Femasys, Inc. · LKF Cannula, Manipulator/Injector, Uterine
Cleared on Nov 22, 2024 as substantially equivalent to K110288 (Femasys, Inc., 2011) after a 136-day review. Its family tree reaches back 3 generations to 1988.
- Decided
- Nov 22, 2024
- Review
- 136 days
- Class
- Class II
- Product code
- LKF
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 3 generations to K881680 (1988). No later device cites it as a predicate yet.
- Root · 3 generations backK881680 Ackrad H/S Procedure TrayAckrad Laboratories · 1988
- 2 generations backK020954 H/S Procedure Tray (5F), H/S Procedure Tray (7F), H/S Elliptosphere…Ackrad Laboratories · 2002
- 1 generation backK110288 Femvue Saline-Air DeviceFemasys, Inc. · 2011
- This deviceK242002 FemVue MINI Saline-Air DeviceFemasys, Inc. · 2024
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K881680 | Ackrad H/S Procedure Tray | Ackrad Laboratories | 1988 | — |
| −2 | K020954 | H/S Procedure Tray (5F), H/S Procedure Tray (7F), H/S Elliptosphere Procedure… | Ackrad Laboratories | 2002 | — |
| −1 | K110288 | Femvue Saline-Air Device | Femasys, Inc. | 2011 | — |
| 0 (this device) | K242002 | FemVue MINI Saline-Air Device | Femasys, Inc. | 2024 | — |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LKF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LKF device
- #1 K241693 FemChec Controlled Saline-Air Device (FCD-250)score 11.6 · 3 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K110288 | Femvue Saline-Air DeviceSummary page 5…r: 21 CFR 884.4530 Regulatory Class: II Product Code: LKF (Cannula, Manipulator/Injector, Uterine) III. PREDICATE DEVICE FemVue® Saline-Air Device (K110288), manufactured by Femasys Inc. The predicate device has not been subject to a design-related recall. IV. DEVICE DESCRIPTION FemV… | 2011 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 36 years and passes through 2 companies; a new generation was cleared every 13.6 years on median.
- None of the 3 ancestors has a recall.
- 3 other devices also cite its predicate K110288.
How does its category compare?
All LKF devicesLKF Cannula, Manipulator/Injector, Uterine: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.
FDA decisions per year · LKF
2in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LKF
136in 2024
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LKF
3in 2022
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LKF
95in 2025
MAUDE reports naming product code LKF, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 3 | 141 | 0 | 36 |
| 2008 | 0 | — | 2 | 59 |
| 2009 | 2 | — | 0 | 53 |
| 2010 | 6 | 178 | 0 | 46 |
| 2011 | 3 | 187 | 0 | 98 |
| 2012 | 0 | — | 2 | 104 |
| 2013 | 3 | 266 | 0 | 53 |
| 2014 | 3 | 169 | 0 | 45 |
| 2015 | 5 | 140 | 0 | 53 |
| 2016 | 1 | — | 0 | 62 |
| 2017 | 1 | — | 0 | 64 |
| 2018 | 4 | 267 | 0 | 23 |
| 2019 | 1 | — | 0 | 76 |
| 2020 | 0 | — | 0 | 119 |
| 2021 | 0 | — | 0 | 189 |
| 2022 | 4 | 79 | 3 | 100 |
| 2023 | 0 | — | 0 | 88 |
| 2024 | 3 | 136 | 0 | 125 |
| 2025 | 2 | — | 0 | 95 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
FemVue MINI is intended to instill a consistent alternating pattern of saline and air as a continuous stream of contrast media into the uterus and fallopian tubes to be used in conjunction with an intrauterine catheter for performance of sono-hysterosalpingogram (Sono HSG).
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K242002 · printed Nov 3, 2026
Cite this page
510(k) Report. “K242002: FemVue MINI Saline-Air Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K242002
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026